STOCK TITAN

Senzime Wins Another Major US Veterans Affairs Contract; Expands Reach of TetraGraph System

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Senzime, a leader in perioperative patient monitoring solutions, secures a significant contract with the US Department of Veterans Affairs to provide TetraGraph Systems. The contract with the North Florida/South Georgia Veterans Health System marks a milestone in expanding Senzime's reach in the US healthcare market. The TetraGraph system aids anesthesiologists in administering drugs accurately, enhancing patient safety post-surgery. CEO Philip Siberg expresses pride in the partnership, highlighting Senzime's dedication to advancing perioperative care for US veterans.
Senzime, leader nelle soluzioni di monitoraggio del paziente perioperatorio, ha ottenuto un importante contratto con il Dipartimento degli Affari dei Veterani degli Stati Uniti per fornire i sistemi TetraGraph. Il contratto con il sistema sanitario dei veterani del Nord Florida/Sud Georgia segna una pietra miliare nell'ampliamento della presenza di Senzime nel mercato sanitario statunitense. Il sistema TetraGraph assiste gli anestesisti nell'amministrazione precisa dei farmaci, migliorando la sicurezza dei pazienti dopo l'intervento. Il CEO Philip Siberg esprime orgoglio per la partnership, sottolineando l'impegno di Senzime nel migliorare l'assistenza perioperatoria per i veterani statunitensi.
Senzime, líder en soluciones de monitoreo perioperatorio de pacientes, asegura un contrato significativo con el Departamento de Asuntos de Veteranos de los EE. UU. para proporcionar Sistemas TetraGraph. El contrato con el Sistema de Salud de Veteranos del Norte de Florida/Sur de Georgia marca un hito en la expansión de la presencia de Senzime en el mercado sanitario de los EE. UU. El sistema TetraGraph ayuda a los anestesiólogos a administrar medicamentos de manera precisa, mejorando la seguridad del paciente postquirúrgica. El CEO Philip Siberg expresa su orgullo por la asociación, destacando la dedicación de Senzime a avanzar en la atención perioperatoria para los veteranos estadounidenses.
Senzime은 수술 중 환자 모니터링 솔루션의 선도 기업으로 미국 재향 군인부와 TetraGraph 시스템을 제공하는 중요한 계약을 확보했습니다. 이 계약은 노스 플로리다/사우스 조지아 재향 군인 보건 시스템과 함께 미국 건강 관리 시장에서 Senzime의 영향력을 확장하는 이정표를 표시합니다. TetraGraph 시스템은 마취 전문의가 약물을 정확하게 투여할 수 있도록 지원하며, 수술 후 환자의 안전을 향상시킵니다. CEO Philip Siberg는 이 파트너십을 자랑스럽게 여기며, 미국 재향 군인을 위한 수술 전 치료의 발전을 위한 Senzime의 헌신을 강조합니다.
Senzime, leader dans les solutions de surveillance des patients en périopératoire, obtient un contrat significatif avec le Département des Anciens Combattants des États-Unis pour fournir les Systèmes TetraGraph. Le contrat avec le système de santé des vétérans du nord de la Floride/sud de la Géorgie marque une étape importante dans l'expansion de Senzime sur le marché des soins de santé américains. Le système TetraGraph aide les anesthésistes à administrer les médicaments avec précision, améliorant ainsi la sécurité des patients après l'opération. Le PDG Philip Siberg exprime sa fierté pour ce partenariat, soulignant l'engagement de Senzime à améliorer les soins périopératoires pour les vétérans américains.
Senzime, ein führender Anbieter von perioperativen Patientenüberwachungslösungen, sichert sich einen bedeutenden Vertrag mit dem US-amerikanischen Veteranenministerium zur Bereitstellung von TetraGraph-Systemen. Der Vertrag mit dem Gesundheitssystem für Veteranen in Nordflorida/Südgeorgien markiert einen Meilenstein in der Erweiterung der Reichweite von Senzime auf dem US-Gesundheitsmarkt. Das TetraGraph-System unterstützt Anästhesisten bei der genauen Verabreichung von Medikamenten und erhöht die Patientensicherheit nach der Operation. CEO Philip Siberg äußert Stolz über die Partnerschaft und betont Senzimes Engagement für die Weiterentwicklung der perioperativen Versorgung für US-Veteranen.
Positive
  • None.
Negative
  • None.

UPPSALA, SE / ACCESSWIRE / April 24, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime, an industry leader in perioperative precision-based patient monitoring solutions, announced today that it has been awarded another major public tender contract by the US Department of Veterans Affairs (VA). The contract to deliver TetraGraph Systems is with the largest VA system in the US - the North Florida/South Georgia Veterans Health System that includes the Malcolm Randall VA Medical Center. Senzime has now delivered over 100 TetraGraph monitors to multiple VA systems across the US.

The VA Health Administration is the largest integrated health care system in the US. Every year, the VA provides care to more than 9 million enrolled US veterans and military personnel at 172 hospitals and over 1,100 outpatient clinics.

"We are honored to yet again be chosen by the Veterans Affairs to expand the reach of our TetraGraph system across the US. This partnership underscores our commitment to advancing perioperative care and supports our mission to ensure the highest standards of patient safety for US veterans, providing these heroes the quality of care they deserve. This important contract also leverages our abilities of becoming a nationwide preferred supplier to the large and important VA system", commented Philip Siberg, CEO of Senzime.

Senzime's TetraGraph is a quantitative neuromuscular train-of-four (TOF) monitoring system used by anesthesiologists at hundreds of leading hospitals across the globe. Its proprietary technology assists anesthesiologists in accurately selecting the appropriate doses of neuromuscular blocking drugs and their antagonists, allowing for patients to safely recover following surgery.

For further information, please contact:

Philip Siberg, CEO of Senzime AB
Phone: +46 (0) 707 90 67 34, e-mail: philip.siberg@senzime.com

About Senzime

Senzime, headquartered in Sweden, is a leading medical device company that develops, manufactures, and markets CE- and FDA-cleared patient monitoring systems. The company provides an innovative portfolio of solutions, including the TetraGraph® and ExSpiron® 2Xi for accurate monitoring of neuromuscular and respiratory functions, typically under and after surgery. The goal is to help eliminate in-hospital complications, and radically reduce health care costs related to surgical and high acuity procedures.

Senzime targets a market opportunity valued more than SEK 40 billion per year, and operates with sales teams in the world's leading markets. The company's shares are listed on Nasdaq Stockholm Main Market (Nasdaq: SEZI) and cross-traded in the US on the OTCQX market (OTCQX: SNZZF). More information is available at senzime.com .

Attachments

Senzime Wins Another Major US Veterans Affairs contract; Expands Reach of TetraGraph System

SOURCE: Senzime



View the original press release on accesswire.com

FAQ

What contract did Senzime win?

Senzime won a major public tender contract with the US Department of Veterans Affairs to deliver TetraGraph Systems.

Which VA system is the contract with?

The contract is with the North Florida/South Georgia Veterans Health System, including the Malcolm Randall VA Medical Center.

How many TetraGraph monitors has Senzime delivered across multiple VA systems?

Senzime has delivered over 100 TetraGraph monitors to multiple VA systems in the US.

What is the TetraGraph system used for?

The TetraGraph system is a quantitative neuromuscular train-of-four monitoring system used by anesthesiologists to administer drugs accurately post-surgery.

Who is the CEO of Senzime?

Philip Siberg is the CEO of Senzime AB.

Senzime AB (publ)

OTC:SNZZF

SNZZF Rankings

SNZZF Latest News

SNZZF Stock Data

73.86M
70.34M
36.31%
24.47%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
Uppsala